Delivering results: the patient perspective - As genomic testing becomes more prevalent, the ability to deliver results sensitively is paramount; so what matters to your patients and their families?

Main|Search|PHGKB






Last Posted: Nov 05, 2018

---

• Delivering results: the patient perspective - As genomic testing becomes more prevalent, the ability to deliver results sensitively is paramount; so what matters to your patients and their families?
  Genomics Education UK, November 5, 2018
• Risks and Benefits of Direct-to-Consumer Genetic Testing Remain Unclear
  B Kuehn, JAMA, October 2018
• About genetic diagnosis of hereditary hemochromatosis.
  Michel Henri et al. Annales de biologie clinique 2018 Apr 76(2) 131
• Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations.
  de Wit M C et al. Prenatal diagnosis 2017 37(13) 1360-1363
• Cell-free DNA for the detection of fetal aneuploidy.
  Goldwaser Tamar et al. Fertility and sterility 2018 109(2) 195-200
• Clinical implications of germline mutations in breast cancer: TP53.
  Schon Katherine et al. Breast cancer research and treatment 2018 167(2) 417-423
• Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis.
  Nambot Sophie et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 20(6) 645-654
• Diagnosis of Inherited Epidermolysis Bullosa in Resource-Limited Settings: Immunohistochemistry Revisited.
  Yenamandra Vamsi Krishna et al. Dermatology (Basel, Switzerland) 2017 233(4) 326-332
• Genetic Markers for Coronary Artery Disease.
  Veljkovic Nevena et al. Medicina (Kaunas, Lithuania) 2018 May 54(3)
• Prenatal diagnosis by chromosomal microarray analysis.
  Levy Brynn et al. Fertility and sterility 2018 109(2) 201-212

more